Marlowe plc (LON:MRL - Get Free Report) shares reached a new 52-week high during trading on Friday . The company traded as high as GBX 350 ($4.54) and last traded at GBX 347 ($4.50), with a volume of 281339 shares changing hands. The stock had previously closed at GBX 336.50 ($4.36).
Wall Street Analysts Forecast Growth
A number of brokerages have recently weighed in on MRL. Berenberg Bank reaffirmed a "buy" rating and issued a GBX 710 ($9.21) price objective on shares of Marlowe in a research note on Wednesday, August 21st. Royal Bank of Canada reaffirmed an "outperform" rating and issued a GBX 690 ($8.95) target price on shares of Marlowe in a research report on Thursday, August 1st.
Check Out Our Latest Research Report on Marlowe
Marlowe Trading Up 4.0 %
The business's 50-day simple moving average is GBX 389.53 and its 200-day simple moving average is GBX 451.10. The company has a market cap of £306.99 million, a price-to-earnings ratio of -2,500.00 and a beta of 0.44. The company has a debt-to-equity ratio of 58.99, a current ratio of 1.24 and a quick ratio of 0.80.
Insiders Place Their Bets
In other Marlowe news, insider Peter M. R. Gaze acquired 15,000 shares of the stock in a transaction on Friday, September 27th. The stock was purchased at an average price of GBX 309 ($4.01) per share, for a total transaction of £46,350 ($60,108.94). 25.30% of the stock is currently owned by insiders.
Marlowe Company Profile
(
Get Free Report)
Marlowe plc provides compliance services and software in the United Kingdom. The company operates in two segments, Governance, Risk and Compliance; and Testing, and Inspection and Certification. It offers health and safety consultancy, risk and audit assessments, environmental, contractor management, and training services; and health and safety support services.
See Also
Before you consider Marlowe, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marlowe wasn't on the list.
While Marlowe currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
